Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study

Cascella, Marco; Coluccia, Sergio; Grizzuti, Mariacinzia; Romano, Maria Cristina; Esposito, Gennaro; Crispo, Anna; Cuomo, Arturo

doi:10.3390/curroncol29080439

Cited by 30 publications

(28 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many recent published works report high patient satisfaction with telemedicine during the first pandemic wave, and suggest that telemedicine could have a role in the future [ 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 ]. However, to ensure high-quality care following the pandemic, further investigations are needed to identify patient groups that can benefit more from this new healthcare delivery.…”

Section: Introductionmentioning

confidence: 99%

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic

et al. 2022

View full text Add to dashboard Cite

Since the beginning of the COVID-19 pandemic, the use of telehealth was rapidly implemented without previous evidence. The ONCOTELEMD study aimed to evaluate the opinion of patients attended via telemedicine during this period and to study factors that condition patient preferences on its use. Included patients had a confirmed cancer diagnosis and were contacted by telephone between 13 March and 30 April 2020, in the Medical Oncology Service of Hospital Parc Taulí, Sabadell. A 12-question survey was presented to them between 4 February and 19 April 2021. Statistical analysis was carried out using chi-square and multivariable logistic regression tests. Six hundred forty-six patients were included; 487 responded to the survey. The median age was 68 years (27–90), 55.2% were female. Most patients had a surveillance visit (65.3%) and were diagnosed with colorectal or breast cancer (43% and 26.5%, respectively); 91.8% of patients were satisfied, and 60% would accept the use of telemedicine beyond the pandemic. Patients aged more than 50 years (OR 0.40; 95% CI, 0.19–0.81; p = 0.01) and diagnosed with breast cancer (OR 0.45; 95% CI, 0.26–0.69; p < 0.001) were less predisposed to adopt telehealth in the future. Patients agreed to be informed via telehealth of scan or lab results (62% and 84%, respectively) but not of new oral or endovenous treatments (52% and 33.5%, respectively). Additionally, 75% of patients had a medium or low-null technologic ability, and 51.3% would only use the telephone or video call to contact health professionals. However, differences were found according to age groups (p < 0.0001). In total, patients surveyed were satisfied with telemedicine and believed telehealth could have a role following the COVID-19 pandemic. Moreover, our results remark on the importance of individualizing the use of telehealth, showing relevant data on patient preferences and digital literacy.

show abstract

Section: Introductionmentioning

confidence: 99%

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Probably, patients suffering from this subtype of cancer pain require greater attention because they are more candidates for visits in person to reevaluate drug therapy or for invasive pain management (16). Moreover, an augmented dropout rate from the telehealth pathway was observed in patients with neuropathic pain (6) probably, these patients. in vivo 37: 385-392 (2023) The modulation between remote visits and rapid hospital access is an important challenge for healthcare systems, demanding for significant resources.…”

Section: Discussionmentioning

confidence: 99%

“…In In previous studies, we assessed the degree of patient satisfaction (6) and developed predictive machine-learning models to identify patients who could have benefited from more remote visits (7). In this study, we sought to report and describe the collected data of a single-center experience on telemedicine employed for the treatment of cancer pain during and after the Covid-19 era.…”

mentioning

confidence: 99%

Implementation of a Hybrid Care Model for Telemedicine-based Cancer Pain Management at the Cancer Center of Naples, Italy: A Cohort Study

Cascella

Schiavo

Grizzuti

et al. 2023

In Vivo

View full text Add to dashboard Cite

Background/Aim: Telemedicine, the remote delivery of healthcare services, represents a great opportunity for cancer pain management. A care model of telemedicine that combines remote visits and hospital access could be an effective and safe strategy for pain management of cancer patients. Patients and Methods: A retrospective study was conducted using the dataset of the telemedicine program at the Istituto Nazionale Tumori of Naples, Italy for assessing the efficacy of a telehealth-based model of care. Demographic, clinical, and process variables were investigated. Results: A total of 226 cases and 489 visits were included in the analysis. The mean age of patients was 63.4 years (SD=12.4 years), and no sex differences were observed. Approximately 55% of patients were ECOG-PS ≤2 and 87% suffered from metastatic disease. More than half of the patients were treated with high doses of opioids. Each patient had a mean of 2 remote visits and half of the patients had more than 1 telehealth consultation. The dropout ratio was 5.3%. Most visits (n=472) were conducted on patients in the Campania Region, Italy. The maximum covered distance from the Cancer Center and the patients' location was 555.22 Km. A significant difference in the overall number of visits (p=0.006) and the number of procapita remote visits (p=0.010) was found, in favor of the group of patients treated before the end of the Covid-19 emergency in Italy, compared to those treated after the pandemic. Conclusion: Despite various positive outcomes, the analysis highlights several weaknesses, such as the need to assist patients with advanced and non-advanced disease located outside the regional territory. Overall, the telehealth processes should be adapted to post-pandemic scenarios towards their implementation in routine clinical practice.

show abstract

“…The overall satisfaction rate from the patients is also pretty high. 43 Using telemedicine technology can effectively and timely monitor and manage pain symptoms and make up for the communication gap found with traditional medicine. Multimodal nursing based on mobile Internet can better achieve good pain management through online connection between patients and nurses.…”

Section: Discussionmentioning

confidence: 99%

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

Chen

Huang

Cui

et al. 2023

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

Background: Pain is the most common cancer-related symptom, but it is often undertreated. Telemedicine is widely used in cancer treatment, but its effectiveness is uncertain. Objective: We aimed to evaluate the impact of telemedicine intervention on pain in patients with cancer. Design: Methodological quality and risk-of-bias evaluation were conducted, and the sources of heterogeneity were explored through subgroup analysis and sensitivity analysis. Data Sources and Methods: PubMed, Embase, Web of Science, Cochrane Library, and clinical trial databases were searched up to 16 August 2022. Randomized controlled trials of the impact of telemedicine intervention regarding pain in patients with cancer were included, and the results related to pain were extracted. Results: Twenty-one randomized controlled trials were selected from 1810 articles. A total of 1454 patients received telemedicine interventions, and 2213 received conventional medical services. Telemedical intervention had a positive effect on improving pain intensity [standard mean deviation (SMD) = −0.28, 95% confidence interval (CI): −0.49 to −0.06, p = 0.01] and pain interference (SMD = −0.41, 95% CI: −0.54 to −0.28, p < 0.00001), with statistical difference between the two groups. The subgroup analysis results showed that the telemedicine subgroup based on an application (SMD = −0.54, 95% CI: −0.91 to −0.18, p = 0.004) and the subgroup with intervention time ⩾ 6 months (SMD = −0.33, 95% CI: −0.52 to −0.13, p = 0.001), both demonstrated significant improvement regarding pain intensity, with significant statistical difference between the two groups. When the follow-up time was ⩾ 6 months, there was no significant difference (SMD = −0.24, 95% CI: −0.55 to 0.07, p = 0.13). Conclusion: Compared with conventional medical services, telemedicine intervention can improve the pain of patients with cancer and is effective and acceptable regarding symptom monitoring. Integrating telemedicine interventions into cancer pain management may be a feasible option. But its long-term effects still need to be confirmed with more high-quality randomized controlled trials in the future. Registration: https://www.crd.york.ac.uk/PROSPERO/ ; CRD42022361990

show abstract

Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study

Cited by 30 publications

References 23 publications

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic

Teleoncology: A Solution for Everyone? A Single-Center Experience with Telemedicine during the Coronavirus Disease 2019 (COVID-19) Pandemic

Implementation of a Hybrid Care Model for Telemedicine-based Cancer Pain Management at the Cancer Center of Naples, Italy: A Cohort Study

The efficacy of telemedicine for pain management in patients with cancer: a systematic review and meta-analysis

Contact Info

Product

Resources

About